Obalon Therapeutics, Inc. (OBLN) Research

Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The company's flagship offering is the Obalon Balloon System, specifically engineered to promote weight reduction in obese patients. This comprehensive system incorporates an ingestible capsule that houses an inflatable balloon connected to a microcatheter. It also includes the Obalon Navigation System console, a specialized hardware and software platform used to precisely monitor and display the balloon's location during its placement. Further components are the Obalon Touch Inflation Dispenser, a semi-automated, portable instrument for inflating the balloon once it's correctly positioned, and a single-use canister containing a gas mixture. By February 27, 2020, Obalon Therapeutics managed three company-owned treatment centers situated in California. The firm was established in 2008 and bases its operations in Carlsbad, California.

Market snapshot

Symbol
OBLN
Price
$3.05
Day change
-5.86%
Market cap
$5.5M
P/E ratio
-0.30x
52-week range
2.948-4.8
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Fresh Tracks Therapeutics, Inc. (FRTX)
  • Greenbrook TMS Inc. (GBNH)
  • LumiraDx Limited (LMDX)
  • Xylo Technologies Ltd. (MDGS)
  • Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)
  • Invitae Corporation (NVTA)
  • Regional Health Properties, Inc. (RHE)
  • Regional Health Properties, Inc. (RHEP)

Recent insider activity

  • Stevenson Sharon — A-Award (27250 shares) on 2020-09-16
  • Stevenson Sharon — A-Award (27250 shares) on 2020-09-16
  • DITTAMORE RAYMOND V — A-Award (27250 shares) on 2020-09-16
  • DITTAMORE RAYMOND V — A-Award (27250 shares) on 2020-09-16
  • Hussainy Nooshin — A-Award (165135 shares) on 2020-06-23

Open Obalon Therapeutics, Inc. (OBLN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.